Etienne Meylan
Overview
Explore the profile of Etienne Meylan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
7434
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Laurent P, Andre F, Bobard A, Deandreis D, Demaria S, Depil S, et al.
Oncoimmunology
. 2024 Dec;
14(1):2432726.
PMID: 39696783
Over the last decade, the annual Immunorad Conference, held under the joint auspicies of Gustave Roussy (Villejuif, France) and the Weill Cornell Medical College (New-York, USA) has aimed at exploring...
2.
Hao Y, Gkasti A, Managh A, Dagher J, Sifis A, Tiron L, et al.
Cancer Immunol Res
. 2024 Nov;
13(2):185-199.
PMID: 39585317
Pleural mesothelioma is a fatal disease with limited treatment options. Recently, pleural mesothelioma management has improved with the development of immune checkpoint inhibitors (ICI). In first-line therapy, dual PD-1 and...
3.
Bodac A, Mayet A, Rana S, Pascual J, Bowler A, Roh V, et al.
EMBO Mol Med
. 2024 Jan;
16(1):158-184.
PMID: 38177532
Elevated peripheral blood and tumor-infiltrating neutrophils are often associated with a poor patient prognosis. However, therapeutic strategies to target these cells are difficult to implement due to the life-threatening risk...
4.
Inhaled dry powder cisplatin increases antitumour response to anti-PD1 in a murine lung cancer model
Davenne T, Percier P, Larbanoix L, Moser M, Leo O, Meylan E, et al.
J Control Release
. 2022 Dec;
353:317-326.
PMID: 36470334
Despite advances in targeted therapies and immunotherapy in lung cancer, chemotherapy remains the backbone of treatment in most patients at different stages of the disease. Inhaled chemotherapy is a promising...
5.
Pinjusic K, Dubey O, Egorova O, Nassiri S, Meylan E, Faget J, et al.
J Immunother Cancer
. 2022 May;
10(5).
PMID: 35580932
Background: Activin-A, a transforming growth factor β family member, is secreted by many cancer types and is often associated with poor disease prognosis. Previous studies have shown that Activin-A expression...
6.
Quail D, Amulic B, Aziz M, Barnes B, Eruslanov E, Fridlender Z, et al.
J Exp Med
. 2022 May;
219(6).
PMID: 35522219
Neutrophils are the first responders to infection and inflammation and are thus a critical component of innate immune defense. Understanding the behavior of neutrophils as they act within various inflammatory...
7.
Bodac A, Meylan E
Semin Immunol
. 2021 Dec;
57:101583.
PMID: 34963565
Neutrophils are critical innate immune cells for the host anti-bacterial defense. Throughout their lifecycle, neutrophils are exposed to different microenvironments and modulate their metabolism to survive and sustain their functions....
8.
Martinez-Usatorre A, Kadioglu E, Boivin G, Cianciaruso C, Guichard A, Torchia B, et al.
Sci Transl Med
. 2021 Aug;
13(606).
PMID: 34380768
Immune checkpoint blockade (ICB) with PD-1 or PD-L1 antibodies has been approved for the treatment of non-small cell lung cancer (NSCLC). However, only a minority of patients respond, and sustained...
9.
Faget J, Peters S, Quantin X, Meylan E, Bonnefoy N
J Immunother Cancer
. 2021 Jul;
9(7).
PMID: 34301813
The immune checkpoint blockade-based immunotherapies are revolutionizing cancer management. Tumor-associated neutrophils (TANs) were recently highlighted to have a pivotal role in modulating the tumor microenvironment and the antitumor immune response....
10.
Ancey P, Contat C, Boivin G, Silvia Sabatino , Pascual J, Zangger N, et al.
Cancer Res
. 2021 Mar;
81(9):2345-2357.
PMID: 33753374
Neutrophils are the most abundant circulating leucocytes and are essential for innate immunity. In cancer, pro- or antitumor properties have been attributed to tumor-associated neutrophils (TAN). Here, focusing on TAN...